On this special episode of the podcast, Emilia Javorsky interviews Sean Ekins about regulating AI drug discovery.
Timestramps: 00:00 Introduction 00:31 Ethical guidelines and regulation of AI drug discovery 06:11 How do we balance innovation and safety in AI drug discovery? 13:12 Keeping dangerous chemical data safe 21:16 Sean’s personal story of voicing concerns about AI drug discovery 32:06 How Sean will continue working on AI drug discovery
Deric Cheng of the Windfall Trust discusses how AGI could transform the social contract, jobs, and inequality, exploring labor displacement, resilient work, new tax and welfare models, and long-term visions for decoupling economic security from employment.
Researcher Oly Sourbut discusses how AI tools might strengthen human reasoning, from fact-checking and scenario planning to honest AI standards and better coordination, and explores how to keep humans central while building trustworthy, society-wide sensemaking.
Technical specialist Nora Ammann of the UK's ARIA discusses how to steer a slow AI takeoff toward resilient, cooperative futures, covering risks from rogue AI and competition to scalable oversight, formal guarantees, secure infrastructure, and AI-supported bargaining.